Back to top
more

Teladoc Health (TDOC)

(Delayed Data from NYSE)

$9.23 USD

9.23
3,854,988

-0.28 (-2.94%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 45% (138 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Elevance Health (ELV) to Post Q3 Earnings: A Beat in the Cards?

by Zacks Equity Research

Elevance Health's (ELV) third-quarter results are likely to reflect improved premiums and net investment income.

Teladoc (TDOC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed at $25.03 in the latest trading session, marking a +1.3% move from the prior day.

Teladoc (TDOC) Stock Moves -0.81%: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $26.81, marking a -0.81% move from the previous day.

How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Teladoc (TDOC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $26.63, marking a +0.79% move from the previous day.

Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Derek Lewis headshot

Time for Investors To Revisit the Pandemic Winners?

by Derek Lewis

Deep in the red year-to-date, do these once big-time winners have any gas left in the tank?

Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $31.67, marking a +1.15% move from the previous day.

Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $30.80, marking a -0.84% move from the previous day.

Teladoc Health, Inc. (TDOC) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Teladoc (TDOC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Teladoc Health (TDOC) Ties Up to Upgrade RPM Care in Canada

by Zacks Equity Research

Teladoc Health (TDOC) teams up with Cloud DX to bring its virtual care capabilities to the latter's platform and dispense advanced RPM solutions to the Canadian residents.

Investors Heavily Search Teladoc Health, Inc. (TDOC): Here is What You Need to Know

by Zacks Equity Research

Zacks.com users have recently been watching Teladoc (TDOC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Derek Lewis headshot

Revisiting the Pandemic Winners: Time to Buy?

by Derek Lewis

Those who flocked to the stay-at-home type of stocks during the pandemic were rewarded handsomely with considerable gains. In 2022, the story has been vividly different.

Teladoc (TDOC) Down 10.3% Despite Q2 Earnings & Sales Beat

by Zacks Equity Research

Teladoc (TDOC) projects total visits between 4.8 million and 5 million for the third quarter.

Here is What to Know Beyond Why Teladoc Health, Inc. (TDOC) is a Trending Stock

by Zacks Equity Research

Teladoc (TDOC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Teladoc (TDOC) delivered earnings and revenue surprises of 38.03% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Neena Mishra headshot

Should You Buy Beaten-Down Biotech Stocks & ETFs?

by Neena Mishra

We highlight 4 ETFs that have started rebounding after a brutal sell-off

Teladoc Health (TDOC) Gears Up for Q2 Earnings: What Lies Ahead?

by Zacks Equity Research

Teladoc Health's (TDOC) second-quarter results are likely to reflect growth in Subscription Access Fees.

Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Teladoc (TDOC) closed the most recent trading day at $43.66, moving +1.06% from the previous trading session.

Elevance Health (ELV) Q2 Earnings Beat on Higher Premiums

by Zacks Equity Research

Elevance Health (ELV) hikes adjusted net income estimate for this year to more than $28.70 per share.

Is Trending Stock Teladoc Health, Inc. (TDOC) a Buy Now?

by Zacks Equity Research

Zacks.com users have recently been watching Teladoc (TDOC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Teladoc (TDOC) closed at $41.81, marking a -0.97% move from the previous day.

Teladoc (TDOC) Widens Primary360 Offerings With New Services

by Zacks Equity Research

Teladoc (TDOC) will provide in-home and on-demand phlebotomy services for its Primary360 members with Scarlet Health's support.

Is Most-Watched Stock Teladoc Health, Inc. (TDOC) Worth Betting on Now?

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Teladoc (TDOC). This makes it worthwhile to examine what the stock has in store.